Literature DB >> 2433835

Expression of cytokeratins and vimentin in epithelial cells of normal and pathologic thyroid tissue.

S C Henzen-Logmans, H Mullink, F C Ramaekers, T Tadema, C J Meijer.   

Abstract

The presence of intermediate filament proteins of the cytokeratin and vimentin type was evaluated in normal and pathologically changed thyroid tissue specimens. Using the indirect immunoperoxidase technique with 4 different cytokeratin monoclonal antibodies: RCK114 (broad spectred), K2080 (broad spectred), RGE53 (directed against component 18, present in simple epithelium) and RKSE60 (directed against component 10, associated with keratinization). Co-expression of cytokeratin and vimentin was evaluated with a double immunoenzyme staining technique. The results indicate that normal and transformed cells express cytokeratins of the non-epidermal type. Cytokeratins of the epidermal type are sometimes present in carcinomas. They do not differentiate in tumour type (i.e. papillary, follicular, anaplastic or medullary carcinoma). The co-expression of cytokeratins and vimentin is not restricted to carcinomas: in a small percentage of cases it is also present in normal epithelial cells of the thyroid gland. Moreover, the distribution pattern of cytokeratins and vimentin within the cell is changed in malignant transformed epithelial cells of the gland and seems to be inversely related to the degree of differentiation of these cells. The implications of our findings for the possible use of cytokeratins and vimentin in diagnostic pathology are discussed.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2433835     DOI: 10.1007/bf00711291

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  24 in total

1.  Different intermediate-sized filaments distinguished by immunofluorescence microscopy.

Authors:  W W Franke; E Schmid; M Osborn; K Weber
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

Review 2.  Diagnostic immunohistochemistry of human tumors. An interim evaluation.

Authors:  R A Erlandson
Journal:  Am J Surg Pathol       Date:  1984-08       Impact factor: 6.394

3.  Characterization of B-cell non-Hodgkin's lymphomas. A study using a panel of monoclonal and heterologous antibodies.

Authors:  P van der Valk; J Jansen; M R Daha; C J Meijer
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1983

Review 4.  Cytocontractile and cytoskeletal elements in pathologic processes. Pathogenetic role and diagnostic value.

Authors:  G Gabbiani; O Kocher
Journal:  Arch Pathol Lab Med       Date:  1983-12       Impact factor: 5.534

Review 5.  Antibodies to intermediate filament proteins in the diagnosis and classification of human tumors.

Authors:  M Miettinen; V P Lehto; I Virtanen
Journal:  Ultrastruct Pathol       Date:  1984       Impact factor: 1.094

6.  Immunochemical identification of intermediate-sized filaments in human neoplastic cells. A diagnostic aid for the surgical pathologist.

Authors:  G Gabbiani; Y Kapanci; P Barazzone; W W Franke
Journal:  Am J Pathol       Date:  1981-09       Impact factor: 4.307

7.  Monoclonal antibodies with different specificities against cytokeratins. An immunohistochemical study of normal tissues and tumors.

Authors:  G N van Muijen; D J Ruiter; M Ponec; C Mey; S O Warnaar
Journal:  Am J Pathol       Date:  1984-01       Impact factor: 4.307

8.  The use of vimentin antibodies in the diagnosis of malignant mesothelioma.

Authors:  B Jasani; R E Edwards; N D Thomas; A R Gibbs
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

9.  Demonstration of keratin in human adenocarcinomas.

Authors:  F Ramaekers; J Puts; O Moesker; A Kant; P Jap; P Vooijs
Journal:  Am J Pathol       Date:  1983-05       Impact factor: 4.307

Review 10.  Antibodies to intermediate filament proteins in the immunohistochemical identification of human tumours: an overview.

Authors:  F C Ramaekers; J J Puts; O Moesker; A Kant; A Huysmans; D Haag; P H Jap; C J Herman; G P Vooijs
Journal:  Histochem J       Date:  1983-07
View more
  11 in total

Review 1.  The utility of some modern techniques in understanding thyroid pathology.

Authors:  Virginia A LiVoisi
Journal:  Endocr Pathol       Date:  1990-06       Impact factor: 3.943

2.  Coexpression of keratin and vimentin in damaged and regenerating tubular epithelia of the kidney.

Authors:  H J Gröne; K Weber; E Gröne; U Helmchen; M Osborn
Journal:  Am J Pathol       Date:  1987-10       Impact factor: 4.307

3.  Patterns of cytokeratin and vimentin expression in the human eye.

Authors:  M Kasper; R Moll; P Stosiek; U Karsten
Journal:  Histochemistry       Date:  1988

4.  Vimentin expression of newly formed rat bile duct epithelial cells in secondary biliary fibrosis.

Authors:  S Milani; H Herbst; D Schuppan; G Niedobitek; K Y Kim; H Stein
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1989

5.  Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelial.

Authors:  U Latza; G Niedobitek; R Schwarting; H Nekarda; H Stein
Journal:  J Clin Pathol       Date:  1990-03       Impact factor: 3.411

6.  Pattern of expression of intermediate cytokeratin filaments in the thyroid gland: an immunohistochemical study of simple and stratified epithelial-type cytokeratins.

Authors:  E Fonseca; J M Nesland; J Höie; M Sobrinho-Simões
Journal:  Virchows Arch       Date:  1997-03       Impact factor: 4.064

7.  Coexpression of cytokeratins and vimentin in common epithelial tumours of the ovary: an immunocytochemical study of eighty-three cases.

Authors:  G Viale; M Gambacorta; P Dell'Orto; G Coggi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1988

8.  Coexpression of cytokeratin and vimentin in Rathke's cysts of the human pituitary gland.

Authors:  M Kasper; U Karsten
Journal:  Cell Tissue Res       Date:  1988-08       Impact factor: 5.249

Review 9.  Immunohistochemical Biomarkers in Thyroid Pathology.

Authors:  Zubair Baloch; Ozgur Mete; Sylvia L Asa
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

10.  CK19 IS A USEFUL MARKER IN DISTINGUISHING FOLLICULAR VARIANT OF PAPILLARY THYROID CARCINOMA FROM BENIGN THYROID LESIONS WITH FOLLICULAR GROWTH PATTERN.

Authors:  F Noroozinia; A Gheibi; B Ilkhanizadeh; A Abbasi
Journal:  Acta Endocrinol (Buchar)       Date:  2016 Oct-Dec       Impact factor: 0.877

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.